234 related articles for article (PubMed ID: 27377999)
1. Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).
Owosho AA; Pedreira Ramalho LM; Rosenberg HI; Yom SK; Drill E; Riedel E; Tsai CJ; Lee NY; Huryn JM; Estilo CL
J Craniomaxillofac Surg; 2016 Sep; 44(9):1408-13. PubMed ID: 27377999
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
Owosho AA; Tsai CJ; Lee RS; Freymiller H; Kadempour A; Varthis S; Sax AZ; Rosen EB; Yom SK; Randazzo J; Drill E; Riedel E; Patel S; Lee NY; Huryn JM; Estilo CL
Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
[TBL] [Abstract][Full Text] [Related]
3. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus.
Teguh DN; Levendag PC; Voet P; van der Est H; Noever I; de Kruijf W; van Rooij P; Schmitz PI; Heijmen BJ
Head Neck; 2008 May; 30(5):622-30. PubMed ID: 18213726
[TBL] [Abstract][Full Text] [Related]
4. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients.
Gebre-Medhin M; Haghanegi M; Robért L; Kjellén E; Nilsson P
Acta Oncol; 2016 Nov; 55(11):1313-1317. PubMed ID: 27595312
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
Kraaijenga SA; Hamming-Vrieze O; Verheijen S; Lamers E; van der Molen L; Hilgers FJ; van den Brekel MW; Heemsbergen WD
Head Neck; 2019 May; 41(5):1387-1394. PubMed ID: 30652390
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2020 Aug; 149():142-149. PubMed ID: 32387489
[TBL] [Abstract][Full Text] [Related]
7. Reducing Trismus After Surgery and Radiotherapy in Oral Cancer Patients: Results of Alternative Operation Versus Traditional Operation.
Tsai CC; Wu SL; Lin SL; Ko SY; Chiang WF; Yang JW
J Oral Maxillofac Surg; 2016 May; 74(5):1072-83. PubMed ID: 26768235
[TBL] [Abstract][Full Text] [Related]
8. Trismus in head and neck cancer patients in Sweden: incidence and risk factors.
Johnson J; van As-Brooks CJ; Fagerberg-Mohlin B; Finizia C
Med Sci Monit; 2010 Jun; 16(6):CR278-82. PubMed ID: 20512090
[TBL] [Abstract][Full Text] [Related]
9. Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.
Rao SD; Saleh ZH; Setton J; Tam M; McBride SM; Riaz N; Deasy JO; Lee NY
Acta Oncol; 2016; 55(1):99-104. PubMed ID: 25920361
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus.
Hague C; Beasley W; Garcez K; Lee LW; McPartlin A; McWilliam A; Ryder D; Sykes AJ; Thomson D; van Herk M; West C; Slevin NJ
Acta Oncol; 2018 Aug; 57(8):1038-1042. PubMed ID: 29630433
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
Chen YY; Zhao C; Wang J; Ma HL; Lai SZ; Liu Y; Han F; Lu LX; Bao Y; Chen M
Cancer; 2011 Jul; 117(13):2910-6. PubMed ID: 21264821
[TBL] [Abstract][Full Text] [Related]
12. Temporal patterns of patient-reported trismus and associated mouth-opening distances in radiotherapy for head and neck cancer: A prospective cohort study.
Thor M; Olsson CE; Oh JH; Hedström J; Pauli N; Johansson M; Deasy JO; Finizia C
Clin Otolaryngol; 2018 Feb; 43(1):22-30. PubMed ID: 28463432
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus.
Hsiung CY; Huang EY; Ting HM; Huang HY
Br J Radiol; 2008 Oct; 81(970):809-14. PubMed ID: 18591201
[TBL] [Abstract][Full Text] [Related]
14. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced trismus in the ARTSCAN head and neck trial.
Lindblom U; Gärskog O; Kjellén E; Laurell G; Levring Jäghagen E; Wahlberg P; Zackrisson B; Nilsson P
Acta Oncol; 2014 May; 53(5):620-7. PubMed ID: 24669774
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
17. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.
Moon DH; Moon SH; Wang K; Weissler MC; Hackman TG; Zanation AM; Thorp BD; Patel SN; Zevallos JP; Marks LB; Chera BS
Oral Oncol; 2017 Sep; 72():98-103. PubMed ID: 28797468
[TBL] [Abstract][Full Text] [Related]
18. Trismus in head and neck cancer patients treated by telecobalt and effect of early rehabilitation measures.
Nagaraja S; Kadam SA; Selvaraj K; Ahmed I; Javarappa R
J Cancer Res Ther; 2016; 12(2):685-8. PubMed ID: 27461633
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and xerostomia after postoperative radiotherapy for oral and oropharyngeal carcinoma.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Head Neck; 2014 Oct; 36(10):1467-73. PubMed ID: 23996878
[TBL] [Abstract][Full Text] [Related]
20. Effects of 3-dimensional conformal or intensity-modulated radiotherapy on dental pulp sensitivity during and after the treatment of oral or oropharyngeal malignancies.
Kataoka SH; Setzer FC; Fregnani ER; Pessoa OF; Gondim E; Caldeira CL
J Endod; 2012 Feb; 38(2):148-52. PubMed ID: 22244627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
